Abstract
Disclosed are compositions comprising levodopa and an antioxidant for inhibiting the development or progression of visual disorders inclusive of visual disorders associated with diabetic retinopathy or Parkinson's disease, and myopia.
| Original language | English |
|---|---|
| Patent number | WO2017177262A1 |
| IPC | A61K 31/198,A61K 31/375,A61P 21/02,A61P 27/10 |
| Priority date | 11/04/16 |
| Filing date | 10/04/17 |
| Publication status | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver